Causes and frequency of blindness in patients with intraocular inflammatory disease.

AIMS/BACKGROUND: Uveitis, an intraocular inflammatory disease, is a significant cause of visual impairment. It is not known how many patients with uveitis will retain visual acuity and how many develop visual impairment or even blindness. The aim of this study was to assess the frequency of blindness in patients with uveitis and, more specifically, to identify the clinical profile of patients at risk for visual loss. METHODS: A cross sectional and retrospective study of 582 patients with uveitis who visited the ophthalmology departments of two university hospitals in the Netherlands was performed. RESULTS: Within the group of 582 patients, 203 (35%) exhibited blindness or visual impairment; bilateral legal blindness developed in 22 (4%) patients, 26 (4.5%) had one blind eye with visual impairment of the other, and nine (1.5%) had bilateral visual impairment. Unilateral blindness developed in 82 (14%) patients, whereas 64 (11%) exhibited unilateral visual impairment. The most important cause of both blindness and visual impairment was cystoid macular oedema (29% and 41%, respectively). Complications of uveitis were encountered in more than half of the patients and 23% underwent one or more surgical procedures. When the patients were subdivided according to anatomical site, those with panuveitis had the worst visual prognosis. The systemic diseases associated with a poor visual prognosis were juvenile chronic arthritis and sarcoidosis. Ocular toxoplasmosis was the most frequent cause of unilateral visual loss. CONCLUSIONS: Cystoid macular oedema is the most frequent complication of uveitis and its occurrence plays a decisive role in the visual outcome of this disease.

[1]  A. Rothova,et al.  Blindness from uveitis in a hospital population in Sierra Leone. , 1994, The British journal of ophthalmology.

[2]  N. Roizen,et al.  Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  C. Foster,et al.  Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. , 1994, Ophthalmology.

[4]  A. Heiligenhaus,et al.  Long-term results of pars plana vitrectomy in the management of complicated uveitis. , 1994, The British journal of ophthalmology.

[5]  C. Foster,et al.  Severity of scleritis and episcleritis. , 1994, Ophthalmology.

[6]  P T de Jong,et al.  Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. , 1994, American journal of ophthalmology.

[7]  D. Lebuisson Complications of cataract and intraocular lens surgery , 1994 .

[8]  M. Derde,et al.  Evaluation of the Possibilities for Preventing Congenital Toxoplasmosis , 1994, American journal of perinatology.

[9]  A. Dick The treatment of chronic uveitic macular oedema. , 1994, The British journal of ophthalmology.

[10]  T. Hikichi,et al.  Role of the vitreous in the prognosis of peripheral uveitis. , 1993, American journal of ophthalmology.

[11]  A. Rothova,et al.  Uveitis and systemic disease. , 1992, The British journal of ophthalmology.

[12]  S. Lightman Uveitis: management , 1991, The Lancet.

[13]  J. Forrester Uveitis: pathogenesis , 1991, The Lancet.

[14]  A. Deutman,et al.  Birdshot chorioretinopathy: clinical characteristics and evolution. , 1988, The British journal of ophthalmology.

[15]  J. Remington,et al.  Toxoplasmosis: the time has come. , 1988, The New England journal of medicine.

[16]  P. Lichter,et al.  Prognostic factors in the uveitis of juvenile rheumatoid arthritis. , 1987, Ophthalmology.

[17]  R. Nussenblatt,et al.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. , 1987, American journal of ophthalmology.

[18]  P T de Jong,et al.  Clinical features of acute anterior uveitis. , 1987, American journal of ophthalmology.

[19]  A. Rothova,et al.  Serology in ocular toxoplasmosis. , 1986, The British journal of ophthalmology.

[20]  L. Laatikainen,et al.  A FOLLOW‐UP STUDY ON SERPIGINOUS CHOROIDITIS , 1981, Acta ophthalmologica.

[21]  C. Wilson,et al.  Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. , 1980, Pediatrics.

[22]  J. Shields,et al.  The clinical course of serpiginous choroidopathy. , 1979, American journal of ophthalmology.

[23]  Blach Rk,et al.  Inflammation in the region of the vitreous base. Pars planitis. , 1976 .

[24]  R. Pruett,et al.  Fluorescein angiography of peripheral uveitis. , 1974, American journal of ophthalmology.

[25]  J. Mamo The rate of visual loss in Behçet's disease. , 1970, Archives of ophthalmology.

[26]  A. Hall,et al.  Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis. , 1994, Ocular immunology and inflammation.

[27]  R. McLeod,et al.  Early and Longitudinal Evaluations of Treated Infants and Children and Untreated Historical Patients with Congenital Toxoplasmosis: The Chicago Collaborative Treatment Trial , 1994 .

[28]  Hamish M. A. Towler,et al.  Visual prognosis in Behçet's disease. , 1993, Ocular immunology and inflammation.

[29]  D. McGavin Reaching for high standards of eye care , 1993 .

[30]  B. Wechsler,et al.  [Ocular prognosis in Behçet's disease]. , 1992, Journal francais d'ophtalmologie.

[31]  C. Alberts,et al.  Uveitis andsystemic disease , 1992 .

[32]  J. ten Doesschate Causes of blindness in The Netherlands , 1982, Documenta ophthalmologica. Advances in ophthalmology.

[33]  G. Chester,et al.  Inflammation in the region of the vitreous base. Pars planitis. , 1976, Transactions of the ophthalmological societies of the United Kingdom.

[34]  A. Dick The treatment of chronic uveitic macular oedema Is immunosuppression enough ? , 2022 .